Sign up to save your podcasts
Or
Share Cedric "Jamie" Rutland, MD - An Animated Exploration of Chronic Fibrosing Interstitial Lung Disease: From Diagnosis to Management in the Era of Antifibrotic Therapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Cedric "Jamie" Rutland, MD - An Animated Exploration of Chronic Fibrosing Interstitial Lung Disease: From Diagnosis to Management in the Era of Antifibrotic Therapy
Go online to PeerView.com/QXS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in interstitial lung disease discusses the diagnosis of and novel and emerging therapies to treat chronic fibrosing interstitial lung disease. Upon completion of this accredited CE activity, participants should be better able to: Recognize risk factors associated with the development of chronic fibrosing interstitial lung disease (CF-ILD), such as having a connective tissue disease, chronic hypersensitivity pneumonitis, and unclassifiable ILD, Identify signs and symptoms indicative of CF-ILD to allow for earlier diagnosis, pulmonary monitoring, and treatment, Discuss the latest clinical data on efficacy and safety for novel and emerging therapies to treat CF-ILD, Develop individualized treatment plans for patients with CF-ILD based on the latest expert recommendations and clinical evidence.
View all episodes
By PVI, PeerView Institute for Medical Education
5
33 ratings
Go online to PeerView.com/QXS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in interstitial lung disease discusses the diagnosis of and novel and emerging therapies to treat chronic fibrosing interstitial lung disease. Upon completion of this accredited CE activity, participants should be better able to: Recognize risk factors associated with the development of chronic fibrosing interstitial lung disease (CF-ILD), such as having a connective tissue disease, chronic hypersensitivity pneumonitis, and unclassifiable ILD, Identify signs and symptoms indicative of CF-ILD to allow for earlier diagnosis, pulmonary monitoring, and treatment, Discuss the latest clinical data on efficacy and safety for novel and emerging therapies to treat CF-ILD, Develop individualized treatment plans for patients with CF-ILD based on the latest expert recommendations and clinical evidence.
More shows like PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast
View all
PeerView Endocrinology & Diabetes CME/CNE/CPE Audio Podcast
5 Listeners
PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast
3 Listeners
PeerView Gastroenterology CME/CNE/CPE Audio Podcast
3 Listeners
PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast
11 Listeners
PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast
5 Listeners
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
28 Listeners
PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
9 Listeners
PeerView Gastroenterology CME/CNE/CPE Video Podcast
3 Listeners
PeerView Internal Medicine CME/CNE/CPE Video Podcast
2 Listeners
PeerView Neuroscience & Psychiatry CME/CNE/CPE Video Podcast
4 Listeners
PeerView Endocrinology & Diabetes CME/CNE/CPE Video Podcast
3 Listeners
PeerView Infectious Diseases CME/CNE/CPE Audio Podcast
5 Listeners
PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio Podcast
5 Listeners
PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video Podcast
2 Listeners
PeerView Infectious Diseases CME/CNE/CPE Video Podcast
0 Listeners
PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast
9 Listeners
PeerView Immunology & Transplantation CME/CNE/CPE Video Podcast
2 Listeners
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
12 Listeners
PeerView Clinical Pharmacology CME/CNE/CPE Video
2 Listeners